Substituting SABR for Systemic Therapy in Oligometastatic Renal Cell Carcinoma - Buying Time or Time to Change?

Overview

Journal Nat Rev Urol

Specialty Urology

Date 2022 Jan 11

PMID 35013590

Authors

Shankar Siva

Alexander V Louie

Affiliations

Soon will be listed here.

Citing Articles

The oligometastatic paradigm and the role of radiotherapy.

Nugent K, Good J Clin Med (Lond). 2023; 23(1):61-64.

PMID: 36697003 PMC: 11046498. DOI: 10.7861/clinmed.2022-0559.

References

Siva S, Bressel M, Wood S, Shaw M, Loi S, Sandhu S . Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial. Eur Urol. 2021; 81(4):364-372. DOI: 10.1016/j.eururo.2021.12.006. View